Augmedix (OTCMKTS:AUGX) is a healthcare technology company that specializes in real-time clinical documentation solutions for physicians and care teams. Leveraging a combination of remote medical scribes, proprietary software and natural language processing, Augmedix captures and converts patient encounters into structured electronic health record (EHR) documentation. This approach allows clinicians to focus on patient care while enhancing the accuracy and completeness of medical records.
The company’s flagship offering, the Augmedix Platform, integrates seamlessly with leading EHR systems to deliver live, cloud-based scribing services. Augmedix also provides telehealth support services, enabling providers to extend the benefits of remote documentation to virtual visits. By reducing the administrative burden on healthcare professionals, Augmedix aims to improve patient engagement, streamline workflows and lower the risk of clinician burnout.
Founded in 2012 and headquartered in Redwood City, California, Augmedix has grown to serve a wide range of medical specialties including primary care, urgent care and behavioral health. The company operates across multiple states in the U.S., partnering with hospitals, health systems and independent physician practices. Over time, Augmedix has expanded its use of artificial intelligence and machine learning to enhance documentation accuracy and operational efficiency.
Augmedix is led by founder and CEO Ian Shakil, supported by an executive team with deep experience in healthcare technology, operations and finance. The company continues to invest in research and development aimed at broadening its service offerings and reinforcing its position as a leading provider of remote scribing and virtual care enablement solutions.
